newsfilter
← Latest News
FDA Approved Drugs·

Approval of Adcetris, Bla #125388

Approval Date: 02/11/2025; Drug Name: Adcetris, Bla #125388; Active Ingredients: BRENTUXIMAB VEDOTIN; Company: Seattle Genetics; Submission Status: Approval; Application Number: 125388

Company
SEATTLE GENETICS
Keywords
SEATTLE GENETICS